Filing Details

Accession Number:
0000899243-15-001566
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-23 17:45:04
Reporting Period:
2015-07-21
Filing Date:
2015-07-23
Accepted Time:
2015-07-23 17:45:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339469 Chiasma Inc CHMA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1648136 7-Med Health Ventures Lp 16B Shenkar Street, P.o.b. 12327
Herzliya Pituach L3 46733
No No Yes No
1648833 Ruth Wertheimer 16B Shenkar Street, P.o.b. 12327
Herzliya Pituach L3 46733
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-21 12,337 $0.00 12,337 No 4 C Direct
Common Stock Acquisiton 2015-07-21 760,656 $0.00 772,993 No 4 C Direct
Common Stock Acquisiton 2015-07-21 514,674 $0.00 1,287,667 No 4 C Direct
Common Stock Acquisiton 2015-07-21 328,515 $0.00 1,616,182 No 4 C Direct
Common Stock Acquisiton 2015-07-21 273,762 $0.00 273,762 No 4 C Indirect Directly owned by Ruth Wertheimer
Common Stock Acquisiton 2015-07-21 93,750 $16.00 93,750 No 4 P Indirect Directly owned by Ruth Wertheimer
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Indirect Directly owned by Ruth Wertheimer
No 4 P Indirect Directly owned by Ruth Wertheimer
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B1' Convertible Preferred Stock Acquisiton 2015-07-21 112,665 $0.00 12,337 $0.00
Common Stock Series C' Convertible Preferred Stock Acquisiton 2015-07-21 6,946,314 $0.00 760,656 $0.00
Common Stock Series D' Convertible Preferred Stock Acquisiton 2015-07-21 4,700,000 $0.00 514,674 $0.00
Common Stock Series E Convertible Preferred Stock Acquisiton 2015-07-21 3,000,000 $0.00 328,515 $0.00
Common Stock Series E Convertible Preferred Stock Acquisiton 2015-07-21 2,500,000 $0.00 273,762 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Indirect
Footnotes
  1. Each outstanding share of the Issuer's Series B-1' Preferred Stock, Series C' Preferred Stock, Series D' Preferred Stock and Series E Preferred Stock converted into 0.109505 of a share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The converted shares had no expiration date.
  2. Besides the shares of Common Stock and warrants to purchase shares of Common Stock held directly by Ruth Wertheimer, she also owns (i) an indirect, 80.5% limited partnership interest in 7 Med Health Ventures LP, as well as (ii) 100% of the outstanding equity interests of the general partner of 7 Med Health Ventures LP. She may therefore be deemed to have an indirect pecuniary interest in the shares of Common Stock and Warrants to purchase Common Stock of the Issuer held by 7 Med Health Ventures LP.
  3. Ruth Wertheimer disclaims beneficial ownership of securities held by 7 Med Health Ventures LP except to the extent of her pecuniary interest therein.
  4. The Reporting Person purchased the shares of Common Stock reported in this row in the Issuer's registered initial public offering in the United States.
  5. Each share of the Issuer's Series B1' preferred stock, Series C preferred stock, Series D' preferred stock and Series E preferred stock was automatically converted on a 9.132-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering. The shares of Series B1', Series C' and Series D' and Series E preferred stock had no expiration date.